These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7585633)

  • 21. Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells.
    Dickopp A; Esche H; Swart G; Seeber S; Kirch HC; Opalka B
    Cancer Gene Ther; 2000 Jul; 7(7):1043-50. PubMed ID: 10917207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus E1A expression enhances the sensitivity of an ovarian cancer cell line to multiple cytotoxic agents through an apoptotic mechanism.
    Brader KR; Wolf JK; Hung MC; Yu D; Crispens MA; van Golen KL; Price JE
    Clin Cancer Res; 1997 Nov; 3(11):2017-24. PubMed ID: 9815592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A truncated minimal-E1a gene with potency to support adenoviral replication mediates antitumor activity by down-regulating Neu expression and preserving Rb function.
    Fang L; Huang Y; Hu X; Sun L; He X; Hu H; Pu Y; Cao X; Luo H; Pan S; Gu J; Su C
    Chem Biol Interact; 2009 Sep; 181(1):1-7. PubMed ID: 19523934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction of adenovirus E1A with p300 family members modulates cellular gene expression to reduce tumorigenicity.
    Miura TA; Cook JL; Potter TA; Ryan S; Routes JM
    J Cell Biochem; 2007 Mar; 100(4):929-40. PubMed ID: 17063489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinoma cell lines become sensitive to DNA-damaging agents by the expression of the adenovirus E1A gene.
    Sánchez-Prieto R; Quintanilla M; Cano A; Leonart ML; Martin P; Anaya A; Ramón y Cajal S
    Oncogene; 1996 Sep; 13(5):1083-92. PubMed ID: 8806698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer.
    Yoo GH; Hung MC; Lopez-Berestein G; LaFollette S; Ensley JF; Carey M; Batson E; Reynolds TC; Murray JL
    Clin Cancer Res; 2001 May; 7(5):1237-45. PubMed ID: 11350889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
    Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
    Liao Y; Zou YY; Xia WY; Hung MC
    Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells.
    Kang KS; Sun W; Nomata K; Morita I; Cruz A; Liu CJ; Trosko JE; Chang CC
    Mol Carcinog; 1998 Apr; 21(4):225-33. PubMed ID: 9585252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
    Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
    Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The N-terminal common domain of simian virus 40 large T and small t antigens acts as a transformation suppressor of the HER-2/neu oncogene.
    Lin YC; Peng JM; Wang WB
    Oncogene; 2000 May; 19(22):2704-13. PubMed ID: 10851070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo antitumor effect of retrovirus-mediated gene transfer of the adenovirus E1a gene.
    Sánchez-Prieto R; Quintanilla M; Martín P; Lleonart M; Cano A; Dotto GP; Ramón y Cajal S
    Cancer Gene Ther; 1998; 5(4):215-24. PubMed ID: 9694073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H; Zhang L; Tang Y; Deisseroth A
    Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer therapy utilizing an adenoviral vector expressing only E1A.
    Hubberstey AV; Pavliv M; Parks RJ
    Cancer Gene Ther; 2002 Apr; 9(4):321-9. PubMed ID: 11960282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C terminus of E1A regulates tumor progression and epithelial cell differentiation.
    Fischer RS; Quinlan MP
    Virology; 1998 Sep; 249(2):427-39. PubMed ID: 9791033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous suppression of progression marker genes in the highly malignant human melanoma cell line BLM after transfection with the adenovirus-5 E1A gene.
    van Groningen JJ; Cornelissen IM; van Muijen GN; Bloemers HP; Swart GW
    Biochem Biophys Res Commun; 1996 Aug; 225(3):808-16. PubMed ID: 8780694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.